CoapTech

CoapTech is a medical device start-up pioneering the world’s first and only ultrasound-based feeding tube placement system.

CoapTech aims to improve medical care delivery for patients young and old around the world.

CoapTech was founded in 2016 by Steven Tropello, alongside with Howard Carolan. The company is headquartered in Baltimore, Maryland.

 

CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patented, disruptive technology called Coaptive Ultrasound which is owned by the company. CoapTech devices will reduce health care costs, and improve safety, quality, patient experience, and access to services around the globe.

 

CoapTech's lead device, PUMA-G enables a point-of-care (i.e. bedside, as opposed to operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers.

 

CoapTech is backed by Hunniwell Lake Ventures, UM Ventures, National Institute of Diabetes and Digestive and Kidney Diseases, TEDCO and others. The company raised $7M in Series B round on Sep 02, 2020. This brings CoapTech's total funding to $10.6M to date.

 

 

  • Year founded: 2016
  • Funding Info: $10.6M over 3 Rounds (Latest Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Baltimore
  • State: Maryland
  • Country: United States
Related businesses